Does CLL Return More Aggressively After Relapse? Dr. Michael Keating, from MD Anderson Cancer Center, joins us for another segment in our “Ask The Expert” series, answering a question about the potential combination of obinutuzamab (Gazyva) and ABT-199 (Venetoclax) and whether this is a treatment approach that could be effective and safe. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter | Follow on Google+ |